EC21 has invested in 1 company and its latest investment was Emmaus on Jan 12, 2016
FOLLOW STATUS
COMPANY
DESCRIPTION
AMOUNT
INVESTMENT DATE
ROUND
EXIT DATE
Emmaus is a California-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of orphan and sickle cell diseases.
